Cargando…
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report
INTRODUCTION: Ovarian cancer ascitic fluid, which contains malignant cells, is usually present in women with an advanced stage disease. There are currently no effective therapies for the treatment of ovarian cancer ascitic fluid. We developed a new therapeutic strategy to target expression of the di...
Autores principales: | Mizrahi, Aya, Czerniak, Abraham, Ohana, Patricia, Amiur, Smadar, Gallula, Jennifer, Matouk, Imad, Abu-lail, Rasha, Birman, Tatiana, Hochberg, Abraham, Levy, Tally |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918631/ https://www.ncbi.nlm.nih.gov/pubmed/20663201 http://dx.doi.org/10.1186/1752-1947-4-228 |
Ejemplares similares
-
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
por: Mizrahi, Aya, et al.
Publicado: (2009) -
H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer
por: Sorin, Vladimir, et al.
Publicado: (2012) -
The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
por: Matouk, Imad, et al.
Publicado: (2013) -
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
por: Matouk, Imad J., et al.
Publicado: (2007) -
Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer
por: Scaiewicz, V., et al.
Publicado: (2010)